FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

ASE Publishes Updated Guideline for Evaluating Prosthetic Heart Valves

The guideline focuses on the use of echocardiography and multimodality imaging in evaluating patients with significant cardiac valvular disease

(DURHAM, NC, January 8, 2024)—A new guideline from the American Society of Echocardiography (ASE) aims to provide clinicians with a comprehensive resource for evaluating prosthetic heart valves (PHVs). Guidelines for the Evaluation of Prosthetic Valve Function with Cardiovascular Imaging: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography replaces the Society’s original guideline published in 2009.

While many principles and recommendations detailed in ASE’s original guideline on PHVs are still current and valid, the document was published prior to several important developments, including the function of percutaneous valves, the use of three-dimensional (3D) echocardiography, and the role of computed tomography (CT) and cardiac magnetic resonance (CMR) in the evaluation of PHVs.

“This new guideline on prosthetic valves was very much needed, as the field has changed so much since 2009, with the introduction of percutaneous valves and improvements in 3D echocardiography and multimodality imaging,” says Chair of the Guideline Writing Group Dr. William A. Zoghbi, Professor and Chairman of the Department of Cardiology at Houston Methodist Hospital in Texas. “It provides clinicians with a roadmap for evaluating PHVs, while aiming to improve patient care and outcomes in the field.”

Dr. Pei-Ni Jone, Co-Chair of the Guideline Writing Group and Director of the Echocardiography Laboratory at the Heart Center, as well as an Attending Physician in Cardiology at Ann & Robert H. Lurie Children’s Hospital of Chicago, adds, “The new guideline provides the clinician with much-needed information on how to evaluate PHVs with cardiac ultrasound, particularly with the added value of 3D echocardiography, and when to use further imaging with cardiac CT or CMR.”

Echocardiography is the first-line modality used to assess prosthetic valve function in patients with significant cardiac valvular disease. However, recent advances in CT and CMR have enhanced their roles in evaluating valvular heart disease. This new guideline offers guidance on which imaging modality can be most helpful for each respective valve and includes the newest valves available.

Additionally, the guideline consolidates critical information gleaned from imaging into tables and key points, while also offering a review of the echocardiographic techniques used and providing recommendations and general guidelines for evaluating prosthetic valve structure, function and regurgitation.

The new guideline is published in the January 2024 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, X, LinkedIn, or Instagram.

###

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

New Guideline Aims to Optimize Care for Pediatric Oncology Patients

The guideline focuses on the use of echocardiography and multimodality imaging in monitoring cardiac function in children with cancer

(DURHAM, NC, December 4, 2023)—A new guideline from the American Society of Echocardiography (ASE) offers recommendations to pediatric cardiologists and oncologists on the application of multimodality imaging in children undergoing cancer treatment.

Cardiovascular ultrasound has long been recognized as a valuable tool in assessing cardiac function and is the first-line imaging technique used to monitor cardiac function during and after cancer treatment in both adult and pediatric patients. However, as the field of pediatric cardio-oncology continues to evolve, children with cancer may also benefit from the addition of other noninvasive imaging techniques.

The newly released guideline, titled “Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography,” provides detailed guidance on how to perform echocardiographic exams, which parameters to use in clinical decision making, and the circumstances under which additional imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), should be considered.

“Cardiovascular complications developing during and after cancer treatment remain a significant challenge and continue to compromise the long-term health of this growing patient cohort,” says Luc Mertens, MD, PhD, FASE, chair of the guideline writing group. “The primary goal of cardiac monitoring is to identify early signs of potentially reversible heart disease and to minimize the risk of progression from asymptomatic to clinically overt heart disease.”

The document also stresses that therapeutic decisions should be based on multidisciplinary discussions among cardiologists, oncology teams, and the patient and their family.

“This guideline highlights the knowledge gaps in the current practice of cardiac monitoring and cautions making therapeutic decisions on cancer treatment for pediatric patients solely on cardiac imaging data,” says Gautam Singh, MD, FASE, co-chair of the writing group. “By standardizing the use of echocardiography and providing evidence-based recommendations, this guideline can help improve long-term cardiac outcomes of pediatric cancer patients.”

This document is published in the December 2023 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter, LinkedIn, or Instagram.

###

The ASE Foundation is Accepting
GivingTuesday Donations November 26-December 2

Fundraising Goal: $35,000

The ASE Foundation is proud to participate in the global generosity movement known as GivingTuesday. Your donation ensures that we continue to foster the next generation of cardiovascular ultrasound professionals, award research grants to investigators, bring cardiac care to areas in need, among other charitable projects in 2024.

Now is your chance to become a leader in ASE and the ASE Foundation! If you are an active member and meet the criteria outlined for the position, ask a friend or colleague who is also an ASE member to submit a nomination on your behalf. All available positions are open to any ASE member, regardless of their specialty, and we are looking for a diverse pool of nominees.

November 30, 2023, is the deadline for candidates to submit all materials required for available positions on the ASE Foundation Board of Directors and Council Steering Committees.

December 7, 2023, is the deadline for candidates to submit all materials required for available positions on the ASE Board of Directors and ASE Executive Committee. Changes were recently made to the criteria for Treasurer, Secretary, and Council Representative. See if you qualify.

Learn More & Apply!

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

American Society of Echocardiography Releases Updated COVID-19 Statement Guideline
The guideline addresses lessons learned from the COVID-19 pandemic and offers new recommendations and guidance to echocardiography laboratories for preparedness in future pandemics

(DURHAM, NC, November 2, 2023)—The COVID-19 pandemic altered the medical landscape and spurred dramatic changes in the practice of echocardiography. While we have moved on from a public health emergency, the emergence of multiple variants makes it an ongoing health issue and an opportune time to reflect on the impact of pandemics.

Considering these developments, the American Society of Echocardiography (ASE) released an updated guideline document to address the current state of COVID-19’s impact on echocardiography and to apply lessons learned to echocardiography laboratory operations in future pandemics.

The new guideline, titled American Society of Echocardiography COVID-19 Statement Update: Lessons Learned and Preparation for Future Pandemics, is an update to the Society’s initial statement released in early 2020 at the start of the pandemic.

The statement offers recommendations on specific indications and decisions about the performance of echocardiography services, infection/transmission mitigation strategies, role of cardiac point-of-care ultrasound/critical care echocardiography, and training in echocardiography, all of which are important areas impacted by current and future pandemics.

“The information included in this guideline will help echocardiography laboratories better plan and prepare by incorporating the lessons we learned the first time around,” says James N. Kirkpatrick, MD, FASE, chair of the guideline writing group. “If in the next pandemic we are once again in contingency or crisis situations, this scientific statement will help direct triage efforts, ensure resources are efficiently employed, and establish plans and protocols helping to prevent staff distress and burnout.”

Additionally, the guideline recognizes the role of professional societies in guiding the development of local policies in conversations between echocardiography laboratory directors and administrators, infection control experts, and staff.

“ASE was one of the first professional societies to offer guidance to echocardiography laboratories around the world during the COVID-19 pandemic,” says ASE Past President (2019-2020) Madhav Swaminathan, MD, FASE, co-chair of the guideline writing group. “The pandemic has evolved since publishing that initial statement, and we have learned that sharing experiences and providing information proactively helps better protect echocardiography service providers and patients.”

This document is a multi-society and multi-national statement comprised of a diverse writing group that includes experts from ASE, the Society for Academic Emergency Medicine and the Society of Critical Care Medicine. It is published in the November 2023 issue of the Journal of the American Society of Echocardiography.

ASE published several earlier COVID-19 statements covering a variety of specific areas, including pediatrics and sonography. View all ASE Guidelines by visiting ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter, LinkedIn, or Instagram.

###

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
aporter@ASEcho.org

American Society of Echocardiography Releases Updated Fetal Echocardiography Guideline
The guideline focuses on the use of echocardiography and multidisciplinary collaboration in fetal cardiac care and evaluation

(DURHAM, NC, July 13, 2023)—Fetal echocardiography is a highly sensitive and specific noninvasive tool used to detect, classify and evaluate fetal cardiovascular diseases. The American Society of Echocardiography (ASE) released a guideline document titled Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography, replacing the original guidelines and standards published by the Society in 2004.

The standards for imaging, reporting and communication of test results in fetal echocardiography continue to advance rapidly, and a considerable amount of new information has become available in the last 20 years. The purpose of this new guideline document is to provide updated recommendations for the performance and interpretation of fetal echocardiography.

The guideline focuses on the detection, classification, risk assessment, and perinatal care planning of pregnancies where the fetus has cardiovascular disease. Much of the information presented is the result of multidisciplinary collaboration and pooling of multicenter data and expertise of subspecialists and other important stakeholders in the care of fetal patients with cardiovascular disease.

The guideline’s writing group was commissioned by ASE’s Pediatric and Congenital Heart Disease Council and lead by Co-Chairs Anita J. Moon-Grady, MD, FASE, and Mary T. Donofrio, MD, FASE. The group presents detailed guidelines for what constitutes a complete fetal echocardiographic examination that can be used as a guide for both learners and experienced practitioners. The Fetal Heart Society, the Society of Pediatric Echocardiography and the American Institute of Ultrasound in Medicine also endorse the document, which is published in the July 2023 issue of the Journal of the American Society of Echocardiography.

“Ongoing research and collaboration have supported efforts toward a better understanding of fetal physiology and disease processes and progression. This has led to significant improvements in fetal diagnosis and in clinical practice and outcomes for patients,” said Dr. Moon-Grady. “The information included in the updated guideline will help practitioners and clinicians maintain the best practice for fetal echocardiography and fetal and perinatal cardiovascular care across disciplines.”

This document and all guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter, LinkedIn, or Instagram.

###